It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2019.
2019 | Chennai, Tamil Nadu, India | ActiveSiloam Pharmaceuticals Private Limited, a active private limited company, was established on 19 November 2019 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24303TN2019PTC132661. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
Employing 24 professional, Its leadership includes Balamurugan (Whole-Time Director), Rajan Gnanaprakasam (Director), Yuvaraj Venkatesan (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 126/1, 2Nd Floor,Ponni Amman Koil Street Selaiyur, Tambaram, Chennai, Tamil Nadu, 600073.
U24303TN2019PTC132661
132661
19 November 2019
₹1.50 M
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Siloam Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balamurugan | Whole-Time Director | 19 Nov 2019 | Current |
| Rajan Gnanaprakasam | Director | 19 Nov 2019 | Current |
| Yuvaraj Venkatesan | Director | 19 Nov 2019 | Current |
| Jamespremkumar Jamespremkumar | Managing Director | 19 Nov 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Siloam Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.55% increase. The company also saw a substantial improvement in profitability, with a 112.07% increase in profit. The company's net worth moved up by a moderate rise of 4.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Siloam Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Siloam Pharmaceuticals has a workforce of 24 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Siloam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siloam Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Siloam Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Siloam Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Balamurugan was appointed as a Whole-time director was appointed as a Whole-time director on 19 Nov 2019 & has been associated with this company since 6 years 1 month . was recorded as a recent event.
Rajan Gnanaprakasam was appointed as a Director was appointed as a Director on 19 Nov 2019 & has been associated with this company since 6 years 1 month . was recorded as a recent event.
Progress on Yuvaraj Venkatesan was appointed as a Director was appointed as a Director on 19 Nov 2019 & has been associated with this company since 6 years 1 month . was documented.
Progress on Jamespremkumar Jamespremkumar was appointed as a Managing Director was appointed as a Managing Director on 19 Nov 2019 & has been associated with this company since 6 years 1 month . was documented.
The CIN of Siloam Pharmaceuticals Private Limited is U24303TN2019PTC132661.
Siloam Pharmaceuticals Private Limited is headquartered at 126/1, 2Nd Floor,Ponni Amman Koil Street Selaiyur, Tambaram, Chennai, Tamil Nadu, 600073.
Siloam Pharmaceuticals Private Limited was incorporated on 19 November 2019.
The current directors of Siloam Pharmaceuticals Private Limited are
The primary industry of Siloam Pharmaceuticals Private Limited is Manufacturing.
Siloam Pharmaceuticals Private Limited is unlisted.
The authorized capital of Siloam Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX